| Gadsden Foot Clinic, P.c. | |
|
306 S 4th St, Gadsden, AL 35901-5213 | |
| (256) 547-1631 | |
| (256) 547-1632 |
| Full Name | Gadsden Foot Clinic, P.c. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot Surgery |
| Location | 306 S 4th St, Gadsden, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710043856 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | (* (Not Available)) | Primary |
| Provider Name | Brooke L Gorham |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1295907087 PECOS PAC ID: 3971676958 Enrollment ID: I20080724000214 |
News Archive
A recent meta-analysis published in Obesity Reviews revealed that children with autism spectrum disorders had a 41.1% higher risk of developing obesity than matched groups of children, and on average, 22 out of 100 children with autism were found to have obesity.
We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.
Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
› Verified 7 days ago
| Provider Name | John V Vanore |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1467518605 PECOS PAC ID: 4385741644 Enrollment ID: I20100913000142 |
News Archive
A recent meta-analysis published in Obesity Reviews revealed that children with autism spectrum disorders had a 41.1% higher risk of developing obesity than matched groups of children, and on average, 22 out of 100 children with autism were found to have obesity.
We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.
Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
› Verified 7 days ago
| Provider Name | Jean Pratt |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1700269123 PECOS PAC ID: 5698019099 Enrollment ID: I20181211002146 |
News Archive
A recent meta-analysis published in Obesity Reviews revealed that children with autism spectrum disorders had a 41.1% higher risk of developing obesity than matched groups of children, and on average, 22 out of 100 children with autism were found to have obesity.
We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.
Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gadsden Foot Clinic, P.c. 306 S 4th St, Gadsden, AL 35901-5213 Ph: (256) 547-1631 | Gadsden Foot Clinic, P.c. 306 S 4th St, Gadsden, AL 35901-5213 Ph: (256) 547-1631 |
News Archive
A recent meta-analysis published in Obesity Reviews revealed that children with autism spectrum disorders had a 41.1% higher risk of developing obesity than matched groups of children, and on average, 22 out of 100 children with autism were found to have obesity.
We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.
Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
› Verified 7 days ago
Dr. Brooke Leann Gorham, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 306 S 4th St, Gadsden, AL 35901 Phone: 256-547-1631 Fax: 256-547-1632 | |
Dr. Michael D Chmielewski, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 230 S 4th St, Gadsden, AL 35901 Phone: 256-549-7890 Fax: 256-549-7891 | |
John V Vanore, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 306 S 4th St, Gadsden, AL 35901 Phone: 256-547-1631 | |
Dr. Henry Lane Bradford, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1020 Tuscaloosa Ave, Gadsden, AL 35901 Phone: 256-492-0131 | |
Dr. Shannon M Deaton, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 230 S 4th St, Gadsden, AL 35901 Phone: 256-549-7890 Fax: 256-549-7891 | |
Jean Pratt, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 306 S 4th St, Gadsden, AL 35901 Phone: 256-547-1631 Fax: 256-547-1632 |